Sanquin 
Welcome,         Profile    Billing    Logout  
 4 Products   23 Diseases  4 Products   9 Trials   24 News 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nanogam (intravenous normal human immunoglobulin) / Sanquin
2008-005659-83: Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial)

Ongoing
4
260
Europe
Nanogam, Nanogam, Nanogam
Erasmus MC
Guillian-Barre syndrome Guillain-Barré Syndroom
 
 
2016-004295-22: Treatment of low platelets in patients suffering from Immune Thrombocytopenia with eltrombopag (oral drug) versus IVIG (intravenous immune globuline) who are in need of surgery.

Ongoing
4
74
Europe
Coated tablet, Infusion, Eltrombopag, Nanogam
Hagaziekenhuis, Hagaziekenhuis
Immune thrombocytopenia patients with low platelets and in need of surgery., immune thrombocytopenia (ITP) can result in bleedings. When in need of surgery platelets might need increasing for adequate clotting after the procedure., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
NCT06223984: Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients

Completed
4
178
RoW
pulse steroid and nanogam
Konya City Hospital
Pulse Steroid and Immunoglobulins Drugs in Covid 19 Patients
11/20
11/20
2012-000067-25: Treatment with chemotherapy for children >1 <19 years of age with acute lymphoblastic leukemia. Behandeling met chemotherapie voor kinderen > 1 en <19 jaar met acute lymfatische leukemie.

Ongoing
3
630
Europe
IVIG, Erwinia L-asparaginase, Oncaspar, RGV 31627, RVG 16986, 30204.00.00, Nanogam 50 mg/ml opslossing voor infusie, Erwinase, Oncaspar, Nanogam 50 mg/ml opslossing voor infusie, Erwinase, Oncaspar
Dutch Childhood Oncology Group, Dutch Childhood Ongology Group
Acute lymphoblastic leukemia in children Acute lymfatische leukemie bij kinderen
 
 
2008-001597-33: Development of chronic disease in newly diagnosed Idiopathic Thrombocytopenic Purpura of Childhood. A randomized controlled study on the influence of treatment with intravenous gammaglobulin on the course of the disease.

Ongoing
3
300
Europe
Nanogam, Nanogam
University Medical Center Utrecht
Acute Idiopathic Thrombocytopenic Purpura (ITP) in children
 
 
2020-006075-15: An infusion of antibodies to COVID-19 for patients with B cell disorder, a randomized (randomized) study (COVID Compromise study).

Ongoing
3
86
Europe
Nanogam, Solution for infusion, Nanogam
Amsterdam UMC, Sanquin Plasma Products BV
COVID-19 disease due to an infection with SARS-CoV2-virus, COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
2020-001710-37: Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial. Intraveneuze immunoglobulines als aanvullende behandeling bij pas gediagnosticeerde myositis: sneller en beter herstel?

Not yet recruiting
3
48
Europe
Nanogam, Sodium Chloride 0.9%, RVG 56083, Solution for infusion, Nanogam, Sodium Chloride 0.9%
Academisch Medisch Centrum, Sanquin Plasma Products B.V.
idiopathic inflammatory myopathies Idiopathische inflammatoire myopathieën, auto-immune inflammation/ disease of the muscles auto-immuun inflammatie/ ziekte van de spieren, Diseases [C] - Immune System Diseases [C20]
 
 
TIMEISMUSCLE, NCT05832034: Add-on Intravenous Immunoglobulins in Early Myositis

Recruiting
2
48
Europe
Immune Globulin Intravenous (Human), Nanogam, Placebo, Sodium chloride or saline 0.9%
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Princess Beatrix Muscle Foundation
Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome, Immune-Mediated Necrotizing Myopathy, Polymyositis, Myositis
02/24
09/24
2021-000864-32: The ConvP COVig PKPD study: an investigation for the use of plasma or antibodies against the novel coronavirus (SARS-CoV-2) De ConvP COVig PKPD studie: een onderzoek naar nuttig gebruik van plasma of antilichamen voor behandeling van het nieuwe coronavirus (SARS-CoV-2)

Ongoing
1/2
104
Europe
Solution for infusion, Nanogam 100 mg/ml
Erasmus MC, ZONMW
COVID-19 or protective effect against in B-cell depleted patients COVID-19 of bescherming tegen deze infectie bij B-cel gedepleteerde patiënten, Patient with a weakened immune system Patiënten met een verminderd immuunsysteem, Diseases [C] - Virus Diseases [C02]
 
 
Aafact (monoclonal purified factor VIII) / Sanquin
2014-005435-14: Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. Combinatiebehandeling van DDAVP en factor VIII-concentraten in patiënten met milde hemofilie A.

Ongoing
4
60
Europe
Solution for injection/infusion, Powder and solvent for solution for injection, Minrin, Octostim, Advate, Kogenate Bayer, Helixate NexGen, ReFacto AF, Aafact, Octanate, NovoEight
Erasmus University Medical Center, ZonMw, Ferring BV, Erasmus University Medical Centre
Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. Milde hemofilie A-patiënten, A clotting disorder in which clotting factor VIII is deficient, which can cause bleeding. In this study we will look at patients with the mild form. Een stollingsstoornis waarin het gehalte van stollingsfactor VIII is verlaagd. Hierdoor kunnen bloedingen veroorzaakt worden. In deze studie kijken we naar patiënten met een milde vorm., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
2013-000909-24: Study of Pharmacokinetic-guided dosing of clottiing factor in Hemophilia. Studie naar farmacokinetisch gestuurde toediening van stollingsfactoren in hemofilie

Ongoing
2
72
Europe
Powder and solvent for solution for injection, Powder and solution for solution for injection, , Advate, Kogenate, Helixate NexGen, Refacto, Benefix, Aafact, NovoEight
Erasmus MC, ZON-MW
Hemophillia hemofilie, hemophillia hemofilie, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
GammaQuin (human normal immunoglobulin) / Sanquin
No trials found
TetaQuin (tetanus Ab) / Sanquin
No trials found
OKL-1111 / Alveron Pharma
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nanogam (intravenous normal human immunoglobulin) / Sanquin
2008-005659-83: Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial)

Ongoing
4
260
Europe
Nanogam, Nanogam, Nanogam
Erasmus MC
Guillian-Barre syndrome Guillain-Barré Syndroom
 
 
2016-004295-22: Treatment of low platelets in patients suffering from Immune Thrombocytopenia with eltrombopag (oral drug) versus IVIG (intravenous immune globuline) who are in need of surgery.

Ongoing
4
74
Europe
Coated tablet, Infusion, Eltrombopag, Nanogam
Hagaziekenhuis, Hagaziekenhuis
Immune thrombocytopenia patients with low platelets and in need of surgery., immune thrombocytopenia (ITP) can result in bleedings. When in need of surgery platelets might need increasing for adequate clotting after the procedure., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
NCT06223984: Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients

Completed
4
178
RoW
pulse steroid and nanogam
Konya City Hospital
Pulse Steroid and Immunoglobulins Drugs in Covid 19 Patients
11/20
11/20
2012-000067-25: Treatment with chemotherapy for children >1 <19 years of age with acute lymphoblastic leukemia. Behandeling met chemotherapie voor kinderen > 1 en <19 jaar met acute lymfatische leukemie.

Ongoing
3
630
Europe
IVIG, Erwinia L-asparaginase, Oncaspar, RGV 31627, RVG 16986, 30204.00.00, Nanogam 50 mg/ml opslossing voor infusie, Erwinase, Oncaspar, Nanogam 50 mg/ml opslossing voor infusie, Erwinase, Oncaspar
Dutch Childhood Oncology Group, Dutch Childhood Ongology Group
Acute lymphoblastic leukemia in children Acute lymfatische leukemie bij kinderen
 
 
2008-001597-33: Development of chronic disease in newly diagnosed Idiopathic Thrombocytopenic Purpura of Childhood. A randomized controlled study on the influence of treatment with intravenous gammaglobulin on the course of the disease.

Ongoing
3
300
Europe
Nanogam, Nanogam
University Medical Center Utrecht
Acute Idiopathic Thrombocytopenic Purpura (ITP) in children
 
 
2020-006075-15: An infusion of antibodies to COVID-19 for patients with B cell disorder, a randomized (randomized) study (COVID Compromise study).

Ongoing
3
86
Europe
Nanogam, Solution for infusion, Nanogam
Amsterdam UMC, Sanquin Plasma Products BV
COVID-19 disease due to an infection with SARS-CoV2-virus, COVID-19, Diseases [C] - Virus Diseases [C02]
 
 
2020-001710-37: Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial. Intraveneuze immunoglobulines als aanvullende behandeling bij pas gediagnosticeerde myositis: sneller en beter herstel?

Not yet recruiting
3
48
Europe
Nanogam, Sodium Chloride 0.9%, RVG 56083, Solution for infusion, Nanogam, Sodium Chloride 0.9%
Academisch Medisch Centrum, Sanquin Plasma Products B.V.
idiopathic inflammatory myopathies Idiopathische inflammatoire myopathieën, auto-immune inflammation/ disease of the muscles auto-immuun inflammatie/ ziekte van de spieren, Diseases [C] - Immune System Diseases [C20]
 
 
TIMEISMUSCLE, NCT05832034: Add-on Intravenous Immunoglobulins in Early Myositis

Recruiting
2
48
Europe
Immune Globulin Intravenous (Human), Nanogam, Placebo, Sodium chloride or saline 0.9%
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Princess Beatrix Muscle Foundation
Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome, Immune-Mediated Necrotizing Myopathy, Polymyositis, Myositis
02/24
09/24
2021-000864-32: The ConvP COVig PKPD study: an investigation for the use of plasma or antibodies against the novel coronavirus (SARS-CoV-2) De ConvP COVig PKPD studie: een onderzoek naar nuttig gebruik van plasma of antilichamen voor behandeling van het nieuwe coronavirus (SARS-CoV-2)

Ongoing
1/2
104
Europe
Solution for infusion, Nanogam 100 mg/ml
Erasmus MC, ZONMW
COVID-19 or protective effect against in B-cell depleted patients COVID-19 of bescherming tegen deze infectie bij B-cel gedepleteerde patiënten, Patient with a weakened immune system Patiënten met een verminderd immuunsysteem, Diseases [C] - Virus Diseases [C02]
 
 
Aafact (monoclonal purified factor VIII) / Sanquin
2014-005435-14: Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. Combinatiebehandeling van DDAVP en factor VIII-concentraten in patiënten met milde hemofilie A.

Ongoing
4
60
Europe
Solution for injection/infusion, Powder and solvent for solution for injection, Minrin, Octostim, Advate, Kogenate Bayer, Helixate NexGen, ReFacto AF, Aafact, Octanate, NovoEight
Erasmus University Medical Center, ZonMw, Ferring BV, Erasmus University Medical Centre
Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. Milde hemofilie A-patiënten, A clotting disorder in which clotting factor VIII is deficient, which can cause bleeding. In this study we will look at patients with the mild form. Een stollingsstoornis waarin het gehalte van stollingsfactor VIII is verlaagd. Hierdoor kunnen bloedingen veroorzaakt worden. In deze studie kijken we naar patiënten met een milde vorm., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
2013-000909-24: Study of Pharmacokinetic-guided dosing of clottiing factor in Hemophilia. Studie naar farmacokinetisch gestuurde toediening van stollingsfactoren in hemofilie

Ongoing
2
72
Europe
Powder and solvent for solution for injection, Powder and solution for solution for injection, , Advate, Kogenate, Helixate NexGen, Refacto, Benefix, Aafact, NovoEight
Erasmus MC, ZON-MW
Hemophillia hemofilie, hemophillia hemofilie, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
GammaQuin (human normal immunoglobulin) / Sanquin
No trials found
TetaQuin (tetanus Ab) / Sanquin
No trials found
OKL-1111 / Alveron Pharma
No trials found

Download Options